Pigment epithelium-derived factor stimulates tumor macrophage recruitment and is downregulated by the prostate tumor

Sofia Halin1, Stina Häggström Rudolfsson, Jennifer A Doll

  • 1Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden. sofia.halin@medbio.umu.se

Neoplasia (New York, N.Y.)
|April 3, 2010
PubMed

Insights

Pigment epithelium-derived factor (PEDF) enhances antitumor immunity by increasing cytotoxic M1 macrophages and reducing tumor growth and metastasis. However, it also promotes macrophage accumulation, which may suppress PEDF and boost lymphangiogenesis, potentially aiding tumor progression.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Pigment epithelium-derived factor (PEDF) is known as an angiogenesis inhibitor.
  • The role of PEDF in the tumor microenvironment, particularly in prostate cancer, is not fully understood.
  • PEDF expression is often reduced during prostate tumor progression.

Purpose of the Study:

  • To investigate the effects of PEDF overexpression on the tumor microenvironment in prostate cancer.
  • To explore PEDF's influence on macrophage recruitment, antitumor immunity, angiogenesis, and metastasis.
  • To identify potential mechanisms, such as tumor necrosis factor alpha (TNFα), that regulate PEDF expression in the tumor microenvironment.

Main Methods:

  • Overexpression of PEDF in orthotopic MatLyLu rat prostate tumors.
  • Analysis of macrophage recruitment and M1 macrophage markers (inducible nitric oxide synthase).
  • Assessment of vascular and lymphangiogenic growth, tumor growth, and lymph node metastasis.
  • Investigation of PEDF downregulation by macrophage-derived tumor necrosis factor alpha (TNFα) in vitro and in vivo.

Main Results:

  • PEDF overexpression increased macrophage recruitment and the proportion of cytotoxic M1 macrophages, suggesting enhanced antitumor immunity.
  • PEDF reduced tumor vascularization, slowed tumor growth, and decreased lymph node metastasis.
  • Contrary to tumor vascularization, extratumoral lymphangiogenesis was increased; TNFα downregulated PEDF expression in prostate tumor cells.

Conclusions:

  • PEDF exhibits multifaceted effects in prostate tumors, inhibiting angiogenesis and metastasis while promoting macrophage accumulation.
  • Accumulating macrophages may initially inhibit tumor growth but can also suppress PEDF and promote lymphangiogenesis, potentially facilitating later tumor progression.
  • Understanding the complex interplay between PEDF, macrophages, and the tumor microenvironment is crucial for developing effective prostate cancer therapies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...